Neuronetics is trading at $2.23, up 5.92%, with broader market strength offering context for the move, though no direct catalyst is established. - The price compares with the October 23 close of $2.11; the S&P 500 and Nasdaq were reported higher. - Neuronetics announced it will report third-quarter results on November 4, but that scheduled event does not establish a direct catalyst for the October 26 move.